Perturbation of the integrity of the blood-brain barrier by fibrinolytic enzymes

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 6, 1998, Pages 471-478

  Nagy, Z ^a   Kolev, K ^a   Csonka, E ^a   Vastag, M ^a   Machovich, R ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Brain edema; Human brain endothelial cells; Miniplasmin; Neutrophil leukocyte elastase; Plasmin

Indexed keywords

LEUKOCYTE ELASTASE; PLASMIN;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; ENDOTHELIUM CELL; ENZYME ACTIVITY; FIBRINOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0031793786     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199809000-00003     Document Type: Article

References (34)

1. Erickson LA. Regulation of vascular fibrinolysis. In: Machovich R (editor): Blood vessel wall and thrombosis. CRC Press: Boca Raton, Florida; 1988. pp. 221-233.
2. Machovich R. Hemostasis. In: Machovich R (editor): Blood vessel wall and thrombosis. CRC Press: Boca Raton, Florida; 1988. pp. 1-80.
3. Bachmann F. Fibrinolysis. In: Verstraete M, Vermylen J, Lijnen HR, Arnont J (editors): Thrombosis and haemostasis. Leuven University Press, Leuven; 1987. pp. 227-265.
4. Bauer PI, Machovich R, Büki KG, Csonka É, Koch SA, Horváth I. Interaction of plasmin with endothelial cells. Biochem J 1984; 218: 119-124.
5. 2-macroglobulin. J Biol Chem 1991; 266: 12329-12336.
6. Nachman RL. Thrombosis and atherogenesis: molecular connections. Blood 1992; 79: 1897-1906.
7. Chang WC, Shi GY, Chow YH, Chang LC, Hau JS, Lin MT, et al. Human plasmin induces a receptor-mediated arachidonate release coupled with G proteins in endothelial cells. Am J Physiol 1993; 264: C271-C281.
8. Turner JS, Redpath GT, Humphries JE, Gonias SL, Vandenberg SR. Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells. Biochem J 1994; 297: 175-179.
9. Nagy Z. Blood-brain barrier and the cerebral endothelium. In: Johanson BB, Owman Ch, Widner H (editors): Pathophysiology of the blood-brain barrier. Elsevier: Amsterdam; 1990. pp. 11-29.
10. Rudd MA, Johnstone MT, Rabbani LE, George D, Ware JA, Loscalzo J. Thrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-D-vasopressin. Circulation 1991; 84: 2568-2573.
11. Conforti G, Dominguez-Jimenez C, Ronne E, Hoyer-Hansen G, Dejana E. Cell-surface plasminogen activation causes a retraction of in vitro cultured human umbilical vein endothelial cell monolayer. Blood 1994; 83: 994-1005.
12. Machovich R. Biology of endothelial cells. In: Machovich R (editor): Blood vessel wall and thrombosis. Boca Raton, Florida: CRC Press; 1988. pp. 115-140.
13. Nagy Z, Kolev K, Csonka É, Pék M, Machovich R. Contraction of human brain endothelial cells induced by thrombogenic and fibrinolytic factors. An in vitro cell culture model. Stroke 1995; 26: 265-270.
14. Zahn FW. Untersuchungen über Thrombose. Bildung der Thromben. Virchow's Arch Path Anat 1875; 62: 81-124.
15. Machovich R, Owen WG. The elastase-mediated pathway of fibrinolysis. Blood Coag Fibrinol 1990; 1: 79-90.
16. Inauen W, Granger DN, Meininger CJ, Schelling ME, Granger HJ, Kvietys PR. Anoxia-reoxygenation-induced, neutrophil-mediated endothelial cell injury: role of elastase. Am J Physiol 1990; 259: H925-H931.
17. Suzuki N, Ishii Y, Kitamura S. Mechanisms for the increased permeability in endothelial monolayers induced by elastase. Mediators Inflammation 1994; 3: 11-16.
18. Tao-Cheng JH, Nagy Z, Brightman MW. Tight junctions of brain endothelium in vitro are enhanced by astroglia. J Neurosci 1987; 7: 3293-3299.
19. Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated low-density lipoprotein. J Cell Biol 1984; 99: 2034-2040.
20. Damus PS, Rosenberg RD. Antithrombin-heparin cofactor. Meth Enzymol 1976; 45: 652-669.
21. Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096.
22. Chase T, Shaw E. Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl. Meth Enzymol 1970; 19: 20-27.
23. Machovich R, Owen WG. An elastase-dependent pathway of plasminogen activation. Biochemistry 1989; 28: 4517-4523.
24. Morrison M. Lactoperoxidase-catalyzed iodination as a tool for investigation of proteins. Meth Enzymol 1980; 70: 210-213.
25. Nagy Z, Mathieson G, Hüttner I. Opening of tight junctions in cerebral endothehum, II: effect of pressure-pulse induced acute arterial hypertension. J Comp Neurol 1979; 185: 579-586.
26. Kolev K, Komorowicz E, Owen WG, Machovich R. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neutrophil leukocyte elastase and cathepsin G. Thromb Haemost 1996; 75: 140-146.
27. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068.
28. Schmidt VA, Vitale E, Bahou WP. Genomic cloning and characterization of the human thrombin receptor gene. Structural similarity to the proteinase activated receptor-2 gene. J Biol Chem 1996; 271: 9307-9312.
29. Zlokovic BV, Wang L, Sun N, Haffke S, Verrall S, Seeds NW, et al. Expression of tissue plasminogen activator in cerebral capillaries: possible fibrinolytic function of the blood-brain barrier. Neurosurgery 1995; 37: 955-961.
30. Pao JS, Sawaya R, Gokaslan ZE, Yung WKA, Goldstein GW, Laterra J. Modulation of serine proteinases and metalloproteinases during morphogenic glial-endothelial interaction. J Neurochem 1996; 66: 1657-1664.
31. Kolev K, Léránt I, Tenekejiev K, Machovich R. Regulation of fibrinoion of fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase by plasma protease inhibitors. J Biol Chem 1994; 269: 17030-17034.
32. Lijnen HR, Collen D. Endothelium in hemostasis and thrombosis. Prog Cardiovasc Dis 1997; 39: 343-350.
33. Wardlaw JM, Warlow CP. Thrombolysis in acute ischemic stroke: does it work? Stroke 1992; 23: 1826-1839.
34. Levine SR, Brott TG. Thrombolytic therapy in cercbrovascular diseases. Progr Cardiovasc Dis 1992; 34: 235-262.